Portaccio E, Magyari M, Havrdova EK, Ruet A, Brochet B, Scalfari A, Di Filippo M, Tur C, Montalban X, Amato MP (2024) Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. Lancet Reg Health Eur 44:100977
Article PubMed PubMed Central Google Scholar
van Noort JM, Baker D, Kipp M, Amor S (2023) The pathogenesis of multiple sclerosis: a series of unfortunate events. Clin Exp Immunol 214(1):1–17
Article PubMed PubMed Central Google Scholar
Rodríguez Murúa S, Farez MF, Quintana FJ (2022) The immune response in multiple sclerosis. Annu Rev Pathol 17:121–139
Wheeler MA, Quintana FJ (2019) Regulation of astrocyte functions in multiple sclerosis. Cold Spring Harb Perspect Med 9(1):a029009
Article CAS PubMed PubMed Central Google Scholar
Bisht P, Rathore C, Rathee A, Kabra A (2024) Astrocyte activation and drug target in pathophysiology of multiple sclerosis. Methods Mol Biol 2761:431–455
Article CAS PubMed Google Scholar
Zhu B, Wang T, Wei X, Zhou Y, Li J (2023) Cpg DNA-triggered upregulation of TLR9 expression affects apoptosis and immune responses in human plasmacytoid dendritic cells isolated from chronic hepatitis B patients. Arch Physiol Biochem 129(2):330–337
Article CAS PubMed Google Scholar
Fiebich BL, Batista CRA, Saliba SW, Yousif NM, de Oliveira ACP (2018) Role of microglia TLRs in neurodegeneration. Front Cell Neurosci 12:329
Article CAS PubMed PubMed Central Google Scholar
Mao P, Reddy PH (2010) Is multiple sclerosis a mitochondrial disease? Biochim Biophys Acta 1802(1):66–79
Article CAS PubMed Google Scholar
Fischer MT, Wimmer I, Höftberger R, Gerlach S, Haider L, Zrzavy T, Hametner S, Mahad D, Binder CJ, Krumbholz M, Bauer J, Bradl M, Lassmann H (2013) Disease-specific molecular events in cortical multiple sclerosis lesions. Brain 136(Pt 6):1799–1815
Article PubMed PubMed Central Google Scholar
Nasi M, Bianchini E, De Biasi S, Gibellini L, Neroni A, Mattioli M, Pinti M, Iannone A, Mattioli AV, Simone AM, Ferraro D, Vitetta F, Sola P, Cossarizza A (2020) Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis. J Neuroimmunol 338:577107
Article CAS PubMed Google Scholar
Pavlovic I, Zjukovskaja C, Nazir FH, Müller M, Wiberg A, Burman J (2024) Cerebrospinal fluid MtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation. Mult Scler Relat Disord 84:105482
Article CAS PubMed Google Scholar
Hernández-Pedro N, Magana-Maldonado R, Ramiro AS, Pérez-De la Cruz V, Rangel-López E, Sotelo J, Pineda B (2016) PAMP-DAMPs interactions mediates development and progression of multiple sclerosis. Front Biosci (Schol Ed) 8(1):13–28
Acioglu C, Mirabelli E, Baykal AT, Ni L, Ratnayake A, Heary RF, Elkabes S (2016) Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: direct versus astrocyte-mediated mechanisms. Brain Behav Immun 56:310–324
Article CAS PubMed Google Scholar
Li L, Ni L, Heary RF, Elkabes S (2020) Astroglial TLR9 antagonism promotes chemotaxis and alternative activation of macrophages via modulation of astrocyte-derived signals: implications for spinal cord injury. J Neuroinflammation 17(1):73
Article CAS PubMed PubMed Central Google Scholar
Li L, Acioglu C, Heary RF, Elkabes S (2021) Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun 91:740–755
Article CAS PubMed Google Scholar
Li L, Ni L, Eugenin EA, Heary RF, Elkabes S (2019) Toll-like receptor 9 antagonism modulates astrocyte function and preserves proximal axons following spinal cord injury. Brain Behav Immun 80:328–343
Article CAS PubMed Google Scholar
Butchi NB, Du M, Peterson KE (2010) Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia 58(6):650–664
Article PubMed PubMed Central Google Scholar
Li Q, Wu P, Du Q, Hanif U, Hu H, Li K (2024) cGAS-STING, an important signaling pathway in diseases and their therapy. MedComm 5(4):e511
Article CAS PubMed PubMed Central Google Scholar
Woo MS, Mayer C, Binkle-Ladisch L, Sonner JK, Rosenkranz SC, Shaposhnykov A, Rothammer N, Tsvilovskyy V, Lorenz SM, Raich L, Bal LC, Vieira V, Wagner I, Bauer S, Glatzel M, Conrad M, Merkler D, Freichel M, Friese MA (2024) STING orchestrates the neuronal inflammatory stress response in multiple sclerosis. Cell 187(15):4043–4060e30
Article CAS PubMed Google Scholar
Wang W, Guo M, Tu X, Jiang M, Zhang CJ (2024) Neuronal STING activation mediates inflammation-induced neurodegeneration via ferroptosis pathways in multiple sclerosis. Biophys Rep 10(6):416–417
Article CAS PubMed PubMed Central Google Scholar
Jiang SY, Tian T, Yao H, Xia XM, Wang C, Cao L, Hu G, Du RH, Lu M (2023) The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of parkinson’s disease via LCN2-dependent astrocyte senescence. Cell Death Differ 30(10):2280–2292
Article CAS PubMed PubMed Central Google Scholar
Flemming A (2024) Neuronal TLR9 signalling crucial for memory formation. Nat Rev Immunol 24(5):306
Maatouk L, Compagnion AC, Sauvage MC, Bemelmans AP, Leclere-Turbant S, Cirotteau V, Tohme M, Beke A, Trichet M, Bazin V, Trawick BN, Ransohoff RM, Tronche F, Manoury B, Vyas S (2018) TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons. Nat Commun 9(1):2450
Article PubMed PubMed Central Google Scholar
Stanbery AG, Newman ZR, Barton GM (2020) Dysregulation of TLR9 in neonates leads to fatal inflammatory disease driven by IFN-γ. Proc Natl Acad Sci U S A 117(6):3074–3082
Article CAS PubMed PubMed Central Google Scholar
Atarashi N, Morishita M, Matsuda S (2024) Activation of innate immune receptor TLR9 by mitochondrial DNA plays essential roles in the chemical long-term depression of hippocampal neurons. J Biol Chem 300(3):105744
Article CAS PubMed PubMed Central Google Scholar
Burgueño JF, Barba A, Eyre E, Romero C, Neunlist M, Fernández E (2016) TLR2 and TLR9 modulate enteric nervous system inflammatory responses to lipopolysaccharide. J Neuroinflammation 13(1):187
Article PubMed PubMed Central Google Scholar
Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Glück S, Thacker VV, Favre L, Mangeat B, Kroese LJ, Krimpenfort P, Prinz M, Ablasser A (2023) cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620(7973):374–380
Article CAS PubMed PubMed Central Google Scholar
Kaur A, Aran KR (2025) Unraveling the cGAS-STING pathway in Alzheimer’s disease: a new frontier in neuroinflammation and therapeutic strategies. Neuroscience 573:430–441
Article CAS PubMed Google Scholar
Ferecskó AS, Smallwood MJ, Moore A, Liddle C, Newcombe J, Holley J, Whatmore J, Gutowski NJ, Eggleton P (2023) STING-triggered CNS inflammation in human neurodegenerative diseases. Biomedicines 11(5):1375
Comments (0)